Feedback / Questions
Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma
https://www.businesswire.com/news/home/20240514537675/en/Equillium-Announces-Interim-Enrollment-Achieved-in-Phase-3-EQUATOR-Study-of-Itolizumab-in-Acute-Graft-Versus-Host-Disease
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next